Biological E
- Hyderabad
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
Hyderabad: Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. According…
- Hyderabad
Hyderabad: Biological E looks to expand, invests Rs 1800 crores
Hyderabad: Global Pharmaceuticals major Biological E Limited on Thursday announced their expansion plans for investment of more than Rs 1800 Crores. The expansion of their existing three facilities will allow for an…
- Hyderabad
Hyderabad based Corbevax gets DGCI nod as COVID-19 booster for 18+
New Delhi: Hyderabad-based Pharmaceuticals firm Biological E Ltd (BE) on Saturday announced that its Covid-19 vaccine Corbevax has been cleared by the Drugs Controller General of India (DCGI) as a heterologous Covid-19…
- Hyderabad
Hyderabad: DFC, Biological E. finalize deal to expand COVID-19 vaccine manufacturing
Hyderabad: The U.S. International Development Finance Corporation (DFC) and Biological E. Limited today unveiled the expansion of Biological E.’s vaccine manufacturing facility in Hyderabad and formalised a $50 million arrangement to expand…
- Hyderabad
COVID-19: Dynavax to supply substance for Biological E’s COVID-19 vaccine candidate
Hyderabad: Biopharmaceutical company Dynavax Technologies Corporation and city-based vaccine and pharma company Biological E. Limited (BE), today announced the execution of a commercial supply agreement of Dynavax’s CpG 1018 TM advanced adjuvant,…
- Hyderabad
Providence to sell 30 mn doses of PTX-Covid19-B to Biological E
Hyderabad: Canada’s Providence Therapeutics Holdings Inc and Biological E Ltd on Tuesday announced the execution of a term sheet for sale of up to 30 million doses of the former’s proprietary messenger RNA…
- India
Biological E to begin phase 3 trials for COVID-19 vaccine
Hyderabad: Hyderabad-based vaccine and pharmaceutical company Biological E. Limited (BE) today announced that it has successfully completed the phase I/II clinical trials of its COVID-19 subunit vaccine candidate in India. The company…
- Featured News
Hyderabad’s Biological E set to give fourth vaccine for India
M Somasekhar Hyderabad: Biological E, the country’s first manufacturer of vaccines in the private sector is all set to launch India’s fourth vaccine against COVID 19 by August 2021. According to the…
